Rockefeller Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Rockefeller Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-111	Closed	-$17K	–	3971
2021 Q2	$17K	Sell	111 -13	-10%	-$2.17K	﹤0.01%	2567
2021 Q1	$18K	Buy	124 +36	+41%	+$4.89K	﹤0.01%	2340
2020 Q4	$11K	Buy	+88	New	+$9.84K	﹤0.01%	2219
2020 Q2	–	Sell	-45	Closed	-$4K	–	2740
2020 Q1	$4K	Buy	+45	New	+$4.39K	﹤0.01%	2056
2019 Q2	–	Sell	-337	Closed	-$37K	–	2077
2019 Q1	$37K	Buy	+337	New	+$35.2K	﹤0.01%	1013

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Rockefeller Capital Management's PRAH Position: Q3 2021 in Review

Rockefeller Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 111 shares — an estimated $17K sold.

Rockefeller Capital Management first reported a position in PRAH in Q1 2019 and held it in 5 quarters. The position peaked at $37K in Q1 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Rockefeller Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Rockefeller Capital Management sold 111 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $17K.
Rockefeller Capital Management first reported a position in PRA Health Sciences, Inc. in Q1 2019 and held it in 5 quarters.
Rockefeller Capital Management's PRA Health Sciences, Inc. position peaked at $37K in Q1 2019.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.